Kawasaki, Japan, August 1, 2025 – (JCN Newswire via SeaPRwire.com) – Fujitsu today announced that it has started research and development towards a superconducting quantum computer with a capacity exceeding 10,000 qubits. Construction is slated for completion in fiscal 2030. The new superconducting quantum computer will operate with 250 logical qubits […]

TOKYO, July 31, 2025 – (JCN Newswire via SeaPRwire.com) – Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that the global revenue(pre-audit basis) of the anti-amyloid-beta protofibril antibody “LEQEMBI®” (generic name: lecanemab) was JPY 23.1 billion for the first quarter of fiscal year 2025 (April 1, 2025 – […]

TOKYO, July 31, 2025 – (JCN Newswire via SeaPRwire.com) – TANAKA PRECIOUS METAL GROUP Co., Ltd. (Headquarters: Chuo-ku, Tokyo; Group CEO: Koichiro Tanaka) has decided to enter into a business partnership with JEPLAN, INC. (Headquarters: Kawasaki City, Kanagawa; Representative Director, President, and Chief Executive Officer: Masaki Takao; hereinafter “JEPLAN”) to reduce […]

TOKYO, July 30, 2025 – (JCN Newswire via SeaPRwire.com) – Sharp Corporation has reached an agreement with Mitsubishi Chemical Corporation (Headquarters: Chiyoda-ku, Tokyo; President: Manabu Tsukimoto), the National Institute of Information and Communications Technology (NICT) (Headquarters: Koganei City, Tokyo; President: Hideyuki Tokuda), and TECHLAB Co., Ltd. (Headquarters: Tama City, Tokyo; […]

Mitsubishi Heavy Industries aims to integrate DCIM (Data Center Infrastructure Management) into its One-stop solutions portfolio to offer digital services to data centers The combination delivers a comprehensive view of data center infrastructure, enabling enhanced visibility, elevated operational efficiency and optimized energy consumption TOKYO, July 29, 2025 – (JCN Newswire […]

TOKYO, July 29, 2025 – (JCN Newswire via SeaPRwire.com) – Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that its in-house discovered tyrosine kinase inhibitor, “LENVIMA®” (generic name: lenvatinib mesylate), in combination with the anti-PD-1 antibody, pembrolizumab, and transarterial chemoembolization (TACE) has been approved by the National […]

– Rationalization of domestic production technologies and strengthening of the system in Japan for manufacturing divertor outer vertical targets for ITER– Seeking to contribute to the ITER Project and provide components for the prototype reactor for fusion energy and startup machines TOKYO, July 23, 2025 – (JCN Newswire via SeaPRwire.com) […]

Showcasing a prototype LEO satellite communication terminal (*1) enabling high-speed, high-capacity communication in areas with limited cellular coverage TOKYO, July 23, 2025 – (JCN Newswire via SeaPRwire.com) – Sharp Corporation (herein after “Sharp”) will exhibit at the 2nd SPEXA – International Space Business Expo, held at Tokyo Big Sight (Koto-ku, Tokyo) […]

TOKYO, July 23, 2025 – (JCN Newswire via SeaPRwire.com) – Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and KYORIN Pharmaceutical Co., Ltd.(Headquarters: Chiyoda-ku, Tokyo, President and CEO: Yutaka Ogihara, “KYORIN”) announced today that Eisai (Thailand) Marketing Co., Ltd. (“Eisai Thailand”), a subsidiary of Eisai, has launched overactive bladder treatment […]

TOKYO, July 22, 2025 – (JCN Newswire via SeaPRwire.com) – Mitsubishi Motors Corporation (hereafter, Mitsubishi Motors) announced the termination of its engine business operation at Shenyang Aerospace Mitsubishi Motors Engine Manufacturing Co., Ltd. (hereinafter, SAME) in China and has terminated the joint venture partnership. Established in August 1997, SAME began […]

Latest findings from Eisai’s robust Alzheimer’s disease (AD) pipeline include results from lecanemab longterm data, an immunoassay for measuring amyloid-B protofibrils in cerebrospinal fluid, and asubcutaneousl form of lecanemab for continued treatment of AD AD is a progressive, relentless disease caused by a continuous underlying neurotoxic process that begins before […]

SINGAPORE, JULY 21, 2025 – (ACN Newswire via SeaPRwire.com) – AGI research company Sapient Intelligence today announced the open-source release of its Hierarchical Reasoning Model (HRM), a brain-inspired architecture that leverages hierarchical structure and multi-timescale processing to achieve substantial computational depth without sacrificing training stability or efficiency. Trained on just […]

TOKYO, Japan, July 18, 2025 – (JCN Newswire via SeaPRwire.com) – Honda will exhibit Honda Koraidon, a future mobility concept, at the 2025 FIM*1 Endurance World Championship “Coca-Cola” Suzuka 8 Hours Endurance Road Race 46th Event*2, to be held from Friday, August 1 to Sunday, August 3 at Suzuka Circuit (Mie […]

TOKYO, July 18, 2025 – (JCN Newswire via SeaPRwire.com) – The SJC2 consortium (*1) announced today with NEC Corporation (NEC; TSE: 6701) the completion of construction and the start of operations for the Southeast Asia-Japan Cable 2 (SJC2), a high-capacity optical submarine cable connecting the Asia region. – Group photo […]

MHI-AP signs three-year service contract for Turkmenistan’s largest fertilizer operation plant MHI-AP will deliver comprehensive after-sales support to enhance the plant’s long-term reliability Garabogazkarbamid Fertilizer Plant internal facade TOKYO, July 17, 2025 – (JCN Newswire via SeaPRwire.com) – Mitsubishi Heavy Industries Asia Pacific Pte. Ltd. (MHI-AP), a subsidiary of Mitsubishi […]

All-New Destinator TOKYO, July 17, 2025 – (JCN Newswire via SeaPRwire.com) – Mitsubishi Motors Corporation (hereafter, Mitsubishi Motors) today unveiled the all-new Destinator midsize SUV in Indonesia. The Destinator will be showcased at the 32nd GAIKINDO Indonesia International Auto Show1, which opens on July 23, with sales to begin the […]

TOKYO, July 17, 2025 – (JCN Newswire via SeaPRwire.com) – Hitachi, Ltd. (hereafter “Hitachi”), Brookfield Japan Kabushiki Kaisha (the Japanese subsidiary of global investment firm Brookfield, hereafter “Brookfield”), and Hartree Partners Singapore Pte. Limited (hereafter “Hartree”), known for its strength in commodity trading, signed a Memorandum of Understanding (MoU) on […]

TOKYO, July 16, 2025 – (JCN Newswire via SeaPRwire.com) – Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that the drug discovery research for Lecanemab (product name: “LEQEMBI®”), a humanized anti-human soluble amyloid B (AB)protofibril monoclonal antibody indicated for early Alzheimer’s disease (early AD*), which was co-developed by […]